The 9 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 220.00, with a high estimate of 220.00 and a low estimate of 125.00. The median estimate represents a +0.71% increase from the last price of 218.45.
The current consensus among 11 polled investment analysts is to Hold stock in GW Pharmaceuticals PLC. This rating has held steady since February, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.02
Reporting Date May 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.